If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Shu Meguro is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 15 Similar Profiles
Type 2 Diabetes Mellitus Medicine & Life Sciences
Glucose Medicine & Life Sciences
C-Peptide Medicine & Life Sciences
Type 1 Diabetes Mellitus Medicine & Life Sciences
Insulin Medicine & Life Sciences
Blood Glucose Medicine & Life Sciences
Hypoglycemia Medicine & Life Sciences
Metformin Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1995 2019

  • 359 Citations
  • 12 h-Index
  • 47 Article
  • 1 Editorial
  • 1 Letter
Open Access
compound A 12
Type 2 Diabetes Mellitus
Hypoglycemic Agents
Open Access
Type 2 Diabetes Mellitus
Dipeptidyl-Peptidase IV Inhibitors
Patient Preference
1 Citation (Scopus)
Glycosylated Hemoglobin A
glycosylated serum albumin


Meguro, S., 2018 Jan 1, In : Japanese Journal of Clinical Chemistry. 47, 1, 1 p.

Research output: Contribution to journalEditorial

13 Citations (Scopus)

Unique clinical and serological features of bullous pemphigoid associated with dipeptidyl peptidase-4 inhibitors

Horikawa, H., Kurihara, Y., Funakoshi, T., Umegaki, N., Takahashi, H., Kubo, A., Tanikawa, A., Kodani, N., Minami, Y., Meguro, S., Itoh, H., Izumi, K., Nishie, W., Shimizu, H., Amagai, M. & Yamagami, J., 2018 Jan 1, (Accepted/In press) In : British Journal of Dermatology.

Research output: Contribution to journalArticle

Dipeptidyl-Peptidase IV Inhibitors
Bullous Pemphigoid